Market Access/ News/ News NICE backs Novartis’ Cosentyx for underdiagnosed back condition Phil Taylor axial spondyloarthritis, Cosentyx, HEOR, inflammatory diseases, NICE, Novartis 0 Comment NICE has extended the range of indications that Novartis’ Cosentyx can be prescribed for by the NHS in Share X NICE backs Novartis’ Cosentyx for underdiagnosed back condition https://pharmaphorum.com/news/nice-backs-novartis-cosentyx-for-underdiagnosed-back-condition/